Argireline vs Acetyl Tetrapeptide-5
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Acetyl Hexapeptide-3, Acetyl Hexapeptide-8
Argireline is the trade name for acetyl hexapeptide-8 (sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2, also called acetyl hexapeptide-3), a synthetic peptide sold in anti-aging creams as a topical, needle-free alternative to Botox. It is designed to relax the muscle contractions behind expression lines. It is a cosmetic ingredient, not an FDA-approved drug, and the human efficacy data are genuinely mixed rather than settled.
Also: Eyeseryl, Ac-beta-Ala-His-Ser-His
Acetyl tetrapeptide-5 is a short synthetic peptide sold by Lipotec (now Lubrizol) as Eyeseryl, made for eye creams that target under-eye puffiness. The pitch is that it reduces fluid leaking into the tissue under the eyes. It is a cosmetic ingredient, and nearly all of the human data comes from the company that sells it.
Key Comparison Insights
- Both peptides belong to the Skin & Hair category, suggesting similar primary applications.
Detailed Comparison
| Attribute | Argireline | Acetyl Tetrapeptide-5 |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Argireline is a fragment that copies the N-terminal end of SNAP-25, a protein nerve endings rely on to release acetylcholine and trigger muscle contraction. By competing for a place in the SNARE complex that powers that release, it is meant to blunt the muscle firing that folds skin into wrinkles, the same target Botox hits, but reversibly and far more weakly. The original lab work showed it really can inhibit neurotransmitter release in cell systems. The unresolved question is whether a topical cream delivers enough peptide deep enough to affect actual facial muscle, since the molecule is water-loving and does not cross the skin barrier easily. | The peptide is acetyl-beta-alanine-histidine-serine-histidine. The manufacturer's lab work claims three effects: it reduces vascular permeability (less fluid seeping out of small blood vessels, tested in an endothelial cell model), it inhibits glycation (sugar damage to proteins like collagen), and it has some ACE-inhibiting activity that is linked to fluid balance. All of that is in vitro and company-generated. An important reality check: under-eye bags have several causes, and a lot of them in older adults come from fat pads pushing forward and loose skin, not fluid. A peptide aimed at fluid cannot touch fat-pad bags, so even in the best case it fits morning puffiness better than structural eye bags. |
| Common Dosing | Limited community data available See research protocols | 1% of the Eyeseryl solution in an eye cream Twice daily |
| Administration | Topical (serums, creams) | Topical (eye creams, gels, serums) |
| Typical Duration | Ongoing use for maintained effects | 28-60 days in manufacturer studies; ongoing use to maintain any effect |
| Best Time to Take | Morning and evening (topical) | Morning and evening, gently patted under the eyes |
Possible Side Effects May vary by individual |
|
|
| Research Summary | The headline 30 percent wrinkle-depth reduction comes from the 2002 Blanes-Mira study, which used a 10 percent peptide oil-in-water emulsion and confirmed the SNARE-interference mechanism in cell assays. That study is the foundation of nearly every marketing claim since. But independent human work is far less flattering: a double-blind split-face trial using VISIA imaging on 19 women found that four weeks of an Argireline serum produced no statistically significant wrinkle improvement over the placebo side, and the authors concluded it is not a substitute for botulinum toxin. A 2025 review found penetration studies in direct conflict, with one reporting around 30 percent stratum-corneum passage and another only about 0.2 percent, and noted that no in vivo study actually demonstrated the muscle-inhibition mechanism it is sold on. Bottom line: real cosmetic peptide, plausible science, but the strongest positive data are old and largely tied to its developers, while better-controlled independent trials are small and underwhelming. Safety is reassuring, with no serious adverse effects reported. | We could not find an independent, peer-reviewed clinical trial of acetyl tetrapeptide-5. The evidence is manufacturer data reported in trade publications. Lipotec's best-known study used a 1% Eyeseryl cream on one eye and placebo on the other in male volunteers aged 30 to 65, twice daily for 28 days, and reported about a 30% reduction in under-eye puffiness volume, with most volunteers rating it positively. Another supplier document describes a 60-day study in 20 women using a cream with a very low peptide level, scored from photos by a dermatologist. Other summaries quote different numbers (17% to 21%) from studies we could not trace to an original paper. The studies differ in concentration, sex, length and how puffiness was measured, so they cannot be pooled. Independent ingredient databases rate the evidence as limited for exactly this reason. Bottom line: plausible for mild fluid puffiness, cheap to try in an eye cream, but not a fix for true eye bags and not backed by independent trials. |
Frequently Asked Questions: Argireline vs Acetyl Tetrapeptide-5
What is the difference between Argireline and Acetyl Tetrapeptide-5?
Argireline is a skin & hair peptide that argireline is the trade name for acetyl hexapeptide-8 (sequence ac-glu-glu-met-gln-arg-arg-nh2, also called acetyl hexapeptide-3), a synthetic peptide sold in anti-aging creams as a topical, needle-free alternative to botox. it is designed to relax the muscle contractions behind expression lines. it is a cosmetic ingredient, not an fda-approved drug, and the human efficacy data are genuinely mixed rather than settled. Acetyl Tetrapeptide-5 is a skin & hair peptide that acetyl tetrapeptide-5 is a short synthetic peptide sold by lipotec (now lubrizol) as eyeseryl, made for eye creams that target under-eye puffiness. the pitch is that it reduces fluid leaking into the tissue under the eyes. it is a cosmetic ingredient, and nearly all of the human data comes from the company that sells it. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Argireline or Acetyl Tetrapeptide-5?
Neither is universally "better" - the choice depends on your specific goals. Argireline is typically used for skin & hair purposes, while Acetyl Tetrapeptide-5 is used for skin & hair. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Argireline and Acetyl Tetrapeptide-5 be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Argireline and Acetyl Tetrapeptide-5 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.